[1] "十三五"国家科技重大专项艾滋病机会性感染课题组.艾滋病合并隐球菌病临床诊疗的专家共识[J].西南大学学报(自然科学版), 2020, 42(7):1-19. [2] AHIMBISBWE C, KWIZERA R, NDYETUKIRA J F, et al.Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting:a prospective cohort study[J].BMC Infect Dis, 2019, 19(1):558. [3] 中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防与控制中心.中国艾滋病诊疗指南(2018版)[J].中华传染病杂志, 2018, 36(12):705-724. [4] US Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Division of AIDS.Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1.[July 2017] [J].Reviewing, 2018, 54:1.26-0.28. [5] CHEN C H, LI H, CHEN H M, et al.Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults:a systematic review and network meta-analysis[J].Sci Rep, 2021, 11(1):8565. [6] KARIMZADEH I, FARSAEI S, KHALILI H, et al.Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity[J]?Expert Opin Drug Saf, 2012, 11(6):969-983. [7] KARIMZADEH I, KHALILI H, DASHTI-KHAVIDAKI S, et al.N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances:a randomized, double-blinded, placebo-controlled, clinical trial[J].Eur J Clin Pharmacol, 2014, 70(4):399-408. [8] SABRA R, BRANCH R A.Amphotericin B nephrotoxicity[J].Drug Saf, 1990, 5(2):94-108. [9] AHIMBISIBWE C, KWIZERA R, NDYETUKIRA J F, et al.Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting:a prospective cohort study[J].BMC Infect Dis, 2019, 19(1):558. [10] World Health Organization.Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018:supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection[M].Geneva:World Health Organization, 2018. [11] BATES D W, SU L, YU D T, et al.Correlates of acute renal failure in patients receiving parenteral amphotericin B[J].Kidney Int, 2001, 60(4):1452-1459. [12] PANAHI-SHOKOUH M, MOGHADDAS A, BADRI S, et al.Pentoxifylline in prevention of amphotericin B-induced nephrotoxicity and electrolyte abnormalities[J].J Res Pharm Pract, 2020, 9(3):135-139. [13] 左依慧, 李贤哲, 胡蔚萍, 等.两性霉素B相关肝损伤发生情况及其影响因素分析[J].药物不良反应杂志, 2020, 22(2):77-84. |